Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer?
OBJECTIVE
This retrospective study was undertaken to evaluate if high resectability rate could improve the long-term outcome of patients with proximal bile duct cancer.


METHODS
Between 1985 and 2001, 50 patients (34 male and 16 female) with proximal bile duct cancer were treated. Thirty-six patients (72%) were considered suitable for surgery, while 14 underwent nonsurgical palliative procedures. Twenty patients had bile duct resection only. Ten patients had Roux-en-Y cholangiojejunostomy with two or three divided segmental hepatic ducts; in 10 patients, the cholangiojejunostomy was performed with four or five divided segmental hepatic ducts. Three patients were treated by palliative transtumoral intubation with Kehr tube. Thirteen patients had bile duct resection plus hepatectomy. Despite the curative intention of the operation, only in 19 (52.7%) patients did the histopathological examination reveal tumor-free margins.


RESULTS
There was no operative mortality. Postoperative morbidity was 25%. Overall 1-, 3-, and 5-year survival of the entire surgical group was 61%, 22.5%, and 9%, respectively. In the 19 patients treated with curative intent the survival at 1, 3, and 5 years was 63.1%, 31.5%, and 15.8%, respectively, while in the group that had palliative treatment it was 45%, 15%, and 0%, respectively.


CONCLUSIONS
Only margins free from tumor can guarantee an improvement in long-term outcome. Increasing resectability improves survival and could offer a chance of better long-term survival.
Veroux
Massimiliano
M
1st Surgical Unit, Department of Surgery, Transplantation and Advanced Technologies, University Hospital of Catania, Catania, Italy.
Madia
Carmelo
C
Fiamingo
Pietro
P
Caglià
Pietro
P
Valastro
Maurizio
M
Amodeo
Corrado
C
Veroux
Pierfrancesco
P
Gagliano
Massimiliano
M
Basso
Stefano
S
D'Amico
Davide Francesco
DF
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001650:Bile Duct Neoplasms / Q000401:mortality* / Q000601:surgery* / Q000628:therapy; D017734:Bile Ducts, Extrahepatic / Q000601:surgery; D005260:Female; D006500:Hepatic Duct, Common / Q000601:surgery; D006801:Humans; D007582:Jejunostomy; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome